STANDARD OFFICE LEASE BY AND BETWEEN BRE CA OFFICE OWNER LLC, a Delaware limited liability company, AS LANDLORD, AND NEURMEDIX, INC., a Delaware corporation, AS TENANT SUITE 150 Governor Executive Center IStandard Office Lease • July 17th, 2017 • Neurmedix, Inc. • Pharmaceutical preparations • California
This Standard Office Lease ("Lease") is made and entered into as of October 20th, 2015, by and between BRE CA OFFICE OWNER LLC, a Delaware limited liability company ("Landlord"), and NEURMEDIX, INC., a Delaware corporation ("Tenant").
ASSIGNMENTNeurmedix, Inc. • July 17th, 2017 • Pharmaceutical preparations
THIS ASSIGNMENT, by Reserva, LLC a corporation duly organized under and pursuant to the laws of California and having a principal place of business at 11601 Wilshire Blvd., #950, Los Angeles, CA 90025 (hereinafter referred to as the Assignor), witnesseth:
ASSIGNMENT AND ASSUMPTION AGREEMENTAssignment and Assumption Agreement • July 17th, 2017 • Neurmedix, Inc. • Pharmaceutical preparations • New York
This Assignment and Assumption Agreement (this “Agreement”), dated as of December 9, 2014, is made by and between Harbor Therapeutics, Inc., a Delaware corporation (the “Seller”), and Reserva, LLC (the “Buyer”).
EQUITY CONTRIBUTION AGREEMENTEquity Contribution Agreement • July 17th, 2017 • Neurmedix, Inc. • Pharmaceutical preparations • California
This EQUITY CONTRIBUTION AGREEMENT (the “Agreement”) is made effective as of June 1, 2014 (the “Effective Date”), by and between NeurMedix, LLC, a California limited liability company formerly known as “Reserva, LLC” with his principal office at 11601 Wilshire Boulevard, Suite 1100, Los Angeles, California 90025 (“NM LLC”), NeurMedix, Inc., a Delaware corporation with his principal office at 11601 Wilshire Boulevard, Suite 1100, Los Angeles, California 90025 (“NM CORP”), and Terren S. Peizer, an individual (“TP”).
ASSET PURCHASE AGREEMENTAssignment and Assumption Agreement • July 17th, 2017 • Neurmedix, Inc. • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”), dated as of December 9, 2014 (the “Effective Date”), is made by and among Harbor Therapeutics, Inc., a Delaware corporation (“Seller”), Harbor Diversified, Inc., a Delaware corporation (“Parent”), and Reserva, LLC (“Buyer”). Buyer, Parent and Seller may be referred to herein each individually as a “Party” and collectively as the “Parties”.
INTELLECTUAL PROPERTY TRANSFER AND ASSIGNMENT AGREEMENTIntellectual Property Transfer and Assignment Agreement • July 17th, 2017 • Neurmedix, Inc. • Pharmaceutical preparations • New York
This Intellectual Property Transfer and Assignment Agreement (“IP Transfer and Assignment”), dated as of December 9, 2014, is made by Harbor Therapeutics, Inc., a Delaware corporation (“Seller”), in favor of Reserva, LLC (“Buyer”), the purchaser of certain assets of Seller pursuant to an Asset Purchase Agreement by and among Seller, Harbor Diversified, Inc., a Delaware corporation (“Parent”), and Buyer, dated as of December 9, 2014 (the “Asset Purchase Agreement”).
Mr. Terren Peizer NeurMedix Inc. 11601 Wilshire Blvd, Suite 1100 Los Angeles, CA 90025 Dear Terren,Understanding and Agreement • July 17th, 2017 • Neurmedix, Inc. • Pharmaceutical preparations
This engagement letter confirms the understanding and agreement (the “Agreement”) between VC Media Partners, LLC (“VCMP” or the “Company”) and NeurMedix Inc. (“NeurMedix” or the “Client”) regarding the retention of VCMP as of June 15th, 2017 as its advisor for the purposes set forth herein.
